ARX
Homeobox protein ARX
Also known as: ARX_HUMAN, CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96QS3
- Gene
- ARX
- Ensembl
- ENSG00000004848
- Chromosome
- X
- Canonical length
- 562 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
OverviewNCBI Gene
This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
562 residues, UniProt reviewed canonical sequence.
>Q96QS3|ARX
1 MSNQYQEEGC SERPECKSKS PTLLSSYCID SILGRRSPCK MRLLGAAQSL PAPLTSRADP
61 EKAVQGSPKS SSAPFEAELH LPPKLRRLYG PGGGRLLQGA AAAAAAAAAA AAAAATATAG
121 PRGEAPPPPP PTARPGERPD GAGAAAAAAA AAAAAWDTLK ISQAPQVSIS RSKSYRENGA
181 PFVPPPPALD ELGGPGGVTH PEERLGVAGG PGSAPAAGGG TGTEDDEEEL LEDEEDEDEE
241 EELLEDDEEE LLEDDARALL KEPRRCPVAA TGAVAAAAAA AVATEGGELS PKEELLLHPE
301 DAEGKDGEDS VCLSAGSDSE EGLLKRKQRR YRTTFTSYQL EELERAFQKT HYPDVFTREE
361 LAMRLDLTEA RVQVWFQNRR AKWRKREKAG AQTHPPGLPF PGPLSATHPL SPYLDASPFP
421 PHHPALDSAW TAAAAAAAAA FPSLPPPPGS ASLPPSGAPL GLSTFLGAAV FRHPAFISPA
481 FGRLFSTMAP LTSASTAAAL LRQPTPAVEG AVASGALADP ATAAADRRAS SIAALRLKAK
541 EHAAQLTQLN ILPGTSTGKE VCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARX can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 78 nTPM
Expression across tissuesHPA
Tissue
- ovary: 78 nTPM
- skeletal muscle: 25 nTPM
- cerebral cortex: 11 nTPM
- testis: 6.8 nTPM
- amygdala: 6.1 nTPM
- basal ganglia: 6.1 nTPM
Single-cell type
- leydig cells: 250 nCPM
- peritubular myoid cells: 109 nCPM
- ovarian stromal cells: 85 nCPM
- neuroendocrine cells: 75 nCPM
- pancreatic islet cells: 64 nCPM
- myonuclei: 47 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 48 nTPM
- basal ganglia: 32 nTPM
- white matter: 28 nTPM
- hypothalamus: 25 nTPM
- hippocampal formation: 18 nTPM
- amygdala: 18 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARX.
Disease | AllUniProt
Conditions ARX is implicated in, by any mechanism.
- Lissencephaly, X-linked 2 (LISX2) MIM:300215
- Developmental and epileptic encephalopathy 1 (DEE1) MIM:308350
- Partington syndrome (PRTS) MIM:309510
- Intellectual developmental disorder, X-linked 29 (XLID29) MIM:300419
- Agenesis of the corpus callosum, with abnormal genitalia (ACCAG) MIM:300004
Disease | GeneticClinVar
142 pathogenic / likely-pathogenic of 973 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy, 1
- Intellectual disability, X-linked, with or without seizures, ARX-related
- X-linked lissencephaly with abnormal genitalia
- Corpus callosum agenesis-abnormal genitalia syndrome
- Partington syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.91
- gnomAD missense Z
- 2.05
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 0% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axon guidance
- cell proliferation in forebrain
- cerebral cortex GABAergic interneuron migration
- cerebral cortex tangential migration
- embryonic olfactory bulb interneuron precursor migration
- epithelial cell fate commitment
- globus pallidus development
- lipid digestion
- negative regulation of transcription by RNA polymerase II
- neuron development
- neuron fate commitment
- organ growth
- positive regulation of gene expression
- positive regulation of organ growth
- positive regulation of transcription by RNA polymerase II
- regulation of epithelial cell proliferation
- regulation of transcription by RNA polymerase II
Molecular functions
- chromatin binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARX in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARX as an antibody target. Whether an autoantibody or antibody against ARX could matter depends on whether native ARX is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARX is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARX as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...